Graves' Disease Clinical Trial
Official title:
Pretreatment With Recombinant Human Thyrotropin (rhTSH) for the Effect on Thyroid Size and Function, and for the Effect of Radioiodine Treatment in Patients With Nodular Goiter. Prospective, Randomized Double-blinded Trials.
The trials in this protocol deals with the effect of pretreatment with rhTSH on radioiodine
treatment of thyroid size and function, in patients with nontoxic and toxic nodular goiter.
It is an introduction of a novel principle, based on prospective, randomized double blind
investigations. Attached to this, we investigate the acute effects of rhTSH on thyroid size
(measured by ultrasonography), both in healthy individuals and in patients with nontoxic
nodular goiter. Thus, the investigations are divided into 4 categories listed below:
1. Prospective randomized double blind study of pretreatment with 0.3 mg recombinant human
TSH for the effect of radioiodine in nontoxic multinodular goiter.
2. Prospective randomized double blind study of the pretreatment with 0.3 mg recombinant
human TSH for the effect of radioiodine on thyroid size and function in patients with a
very large (>100 ml) nontoxic or toxic goiter.
3. Does administration of 0.9 mg recombinant human TSH affect thyroid function and volume
in healthy individuals? A randomized double-blind cross-over trial.
4. Does administration of 0.3 mg recombinant human TSH affect thyroid function and volume
in healthy individuals and in patients with multinodular non-toxic goiter? A randomized
double-blind cross-over trial.
As a final note we investigate, in a pilot-study;
5. The influence of rhTSH on thyroid radioiodine uptake in patients with hyperthyroidism
treated with continuous block-replacement therapy.
n/a
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double-Blind, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01950260 -
Early Levothyroxine Post Radioactive Iodine
|
Phase 2/Phase 3 | |
| Completed |
NCT01269749 -
Radioactive Iodide Therapy for Pediatric Graves' Disease
|
Phase 2 | |
| Recruiting |
NCT06068179 -
Graves' Disease Remission Study: MycoMeth Combo
|
Phase 2/Phase 3 | |
| Recruiting |
NCT02114619 -
Comparative Study of Different I-131 Doses in Graves' Disease
|
N/A | |
| Completed |
NCT04383795 -
Change of Gut Microbiome in the Treatment of Graves' Disease
|
||
| Completed |
NCT02384668 -
D-vitamin And Graves' Disease; Morbidity And Relapse Reduction
|
N/A | |
| Completed |
NCT01885533 -
Post-Radioiodine Graves' Management: The PRAGMA-Study
|
N/A | |
| Completed |
NCT01534169 -
Function of Regulatory T Cells Improved by Dexamethasone in Graves' Patients
|
Phase 1 | |
| Completed |
NCT00917241 -
Prevention Relapse of Graves' Disease by Intrathyroid Injection of Dexamethasone
|
Phase 4 | |
| Completed |
NCT00004660 -
Randomized Study of Sequential Orbital Radiotherapy for Graves' Ophthalmopathy
|
N/A | |
| Completed |
NCT02205801 -
Study of the Efficacy of Local Analgesia as an Adjunct to General Anesthesia in Thyroidectomy and Parathyroidectomy
|
N/A | |
| Recruiting |
NCT02620085 -
Thyroid Disease and Personality Study
|
N/A | |
| Completed |
NCT00958113 -
Autoimmune Thyroid Disease Genetic Study
|
N/A | |
| Completed |
NCT02727738 -
Treatment of Graves' Hyperthyroidism With Selenium Plus Methimazole
|
N/A | |
| Completed |
NCT00697528 -
Color Doppler Imaging of Orbital Venous Flow in Grave's Orbitopathy
|
N/A | |
| Completed |
NCT00150124 -
Block-replacement Therapy During Radioiodine Therapy
|
Phase 4 | |
| Completed |
NCT03535090 -
Coagulation After Intravenous Methylprednisolone Administration
|
||
| Not yet recruiting |
NCT02373995 -
Role of the Microbiome in Graves' Orbitopathy
|
Phase 1/Phase 2 | |
| Completed |
NCT00505011 -
Genetic Polymorphisms Associated With Cigarette Smoking and Risk of Graves’ Disease
|
N/A | |
| Completed |
NCT02107794 -
Shared Decision Making in Graves Disease - Graves Disease (GD) Choice
|
N/A |